Daniel Associates

Get in-depth analysis of how COVID-19 is impacting the Drug Discovery Services Market by Process (Target Selection, Validation, Lead Optimization), Type (Medicinal Chemistry, DMPK), Drug Type (Biologics, Small Molecules), Therapeutic (Oncology, Neurology), Company (Tier 1, 2, 3) & Region – Global Forecast to 2025

  • The Drug Discovery Services Market was valued at USD XX Billion in 2019 and is estimated to reach USD XX Billion by 2025, at a CAGR of XX% during the forecast period. The base year used for this study is 2019, and the forecast period considered is between 2020 and 2025.

    The objectives of the study are as follows:

    • To define, describe, and forecast the Drug Discovery Services Market by Process (Target Selection, Validation, Lead Optimization), Type (Medicinal Chemistry, DMPK), Drug Type (Biologics, Small Molecules), Therapeutic (Oncology, Neurology), Company (Tier 1, 2, 3) & Region
    • To forecast the market size in terms of value for various segments with respect to five main regions: North America, Europe, APAC, Middle East & Africa and Latin America.
    • To provide detailed information regarding the major factors influencing the growth of the Drug Discovery Services Market (drivers, restraints, opportunities, and industry-specific challenges)
    • To analyze the opportunities in the market for various stakeholders by identifying the high-growth segments of the Drug Discovery Services Market
    • To strategically profile the key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing the competitive landscape for the market leaders
    • To analyze competitive developments such as new product launches and developments; agreements and contracts; mergers and acquisitions; and expansions in the global Drug Discovery Services Market

    The years considered for the study are:

    Base Year – 2019         Estimated Year – 2020         Forecast Period – 2025

    For company profiles in the report, 2019 has been considered as the base year. In certain cases, wherein information is unavailable for the base year, the years prior to it have been considered.

    Scope of the Report:

    Drug Discovery Services Market, By Process
    Target Selection
    Target Validation
    Hit-To-Lead Identification
    Lead Optimization
    Candidate Validation

    Drug Discovery Services Market, By Type
    Medicinal Chemistry
    Biology Services
    Drug Metabolism and Pharmacokinetics (DMPK)

    Drug Discovery Services Market, By Drug Type
    Small Molecules
    Biologics Infectious Disease Diagnostics

    Drug Discovery Services Market, By Company Type
    Tier 1 Pharmaceutical Companies
    Tier 2 Pharmaceutical Companies
    Tier 3 Pharmaceutical Companies

    Drug Discovery Services Market, By Therapeutic Area
    Oncology
    Neurology
    Infectious and Immune System Diseases
    Digestive System Diseases
    Cardiovascular Diseases
    Other Therapeutic Areas

    Drug Discovery Services Market, By Region
    Asia-Pacific
    North America
    Europe
    Latin America
    Middle East & Africa

  • Table of Contents

    1 Introduction

    2 Research Methodology

    3 Executive Summary

    4 Premium Insights
        4.1 Drug Discovery Services Market Overview
        4.2 Drug Discovery Services Market, By Process
        4.3 Drug Discovery Services Market, By Type
        4.4 Drug Discovery Services Market, By Drug Type
        4.5 Drug Discovery Services Market, By Therapeutic Area
        4.6 Drug Discovery Services Market, By Region

    5 Market Overview
        5.1 Introduction
        5.2 Market Dynamics
               5.2.1 Drivers
                        5.2.1.1 Growing R&D Expenditure In The Industry
                        5.2.1.2 Increasing Demand For Outsourcing Testing And Clinical Trial Services
                        5.2.1.3 Initiatives For Research On Rare Diseases And Orphan Drugs
                        5.2.1.4 Focus On Drug Discovery
               5.2.2 Restraints
                        5.2.2.1 High Cost Of Drug Discovery And Development
                        5.2.2.2 Stringent Regulations Governing Drug Discovery And Animal Usage
               5.2.3 Opportunities
                        5.2.3.1 Growth In The Biologics Market
                        5.2.3.2 Patent Expiries
                        5.2.3.3 Emerging Markets

    6 Drug Discovery Services Market, By Process
        6.1 Introduction
        6.2 Target Selection
        6.3 Target Validation
        6.4 Hit-To-Lead Identification
        6.5 Lead Optimization
        6.6 Candidate Validation

    7 Drug Discovery Services Market, By Type
        7.1 Introduction
        7.2 Medicinal Chemistry Services
        7.3 Biology Services
        7.4 Drug Metabolism & Pharmacokinetics

    8 Drug Discovery Services Market, By Drug Type
        8.1 Introduction
        8.2 Small-Molecule Drugs
        8.3 Biologic Drugs

    9 Drug Discovery Services Market, By Therapeutic Area
        9.1 Introduction
        9.2 Oncology
        9.3 Neurology
        9.4 Infectious and Immune System Diseases
        9.5 Digestive System Diseases
        9.6 Cardiovascular Diseases
        9.7 Other Therapeutic Areas

    10 Drug Discovery Services Market, By Company Type
         10.1 Introduction
         10.2 Tier 1 Pharmaceutical Companies
         10.3 Tier 2 Pharmaceutical Companies
         10.4 Tier 3 Pharmaceutical Companies

    11 Drug Discovery Services Market, By Region
         11.1 Introduction
         11.2 North America
         11.3 Europe
         11.4 Asia Pacific
         11.5 Middle East & Africa
         11.6 Latin America

    12 Competitive Landscape

    13 Company Profiles
         13.1 Laboratory Corporation Of America Holdings
         13.2 Eurofins Scientific Se
         13.3 Charles River Laboratories International
         13.4 Evotec Se
         13.5 Thermo Fisher Scientific
         13.6 Syngene International Limited
         13.7 Jubilant Lifesciences
         13.8 Genscript Biotech Corporation
         13.9 Piramal Enterprises Limited
         13.10 Wuxi Apptec
         13.11 Selvita (Formerly Selvita Cro S.A.)
         13.12 Frontage Holdings
         13.13 Pharmaceutical Product Development, Llc
         13.14 Shanghai Medicilon, Inc.
         13.15 Albany Molecular Research, Inc.
         13.16 Aurigene Discovery Technologies (A Subsidiary Of Dr. Reddy’s Laboratories)
         13.17 Domainex Ltd.
         13.18 Chempartner Co., Ltd.
         13.19 Tcg Lifesciences Pvt. Limited
         13.20 Viva Biotech (Shanghai) Ltd.

    (Business Overview, Products & Services, Recent Developments, Financials, SWOT Analysis)*
    *Details Might Not Be Captured in Case of Unlisted Companies.



  • Select User License